JL 13, a potential successor to clozapine, is less sensitive to oxidative phenomena.
The oxidation behaviour of JL 13, a promising antipsychotic, was investigated in comparison with clozapine and loxapine, by measuring their direct "radical scavenging" abilities and their efficacies in inhibiting the lipid peroxidation. In the lipid peroxidation system, the reactivity of these compounds with free radicals produced by gamma-irradiation of linoleic acid may be presented as follows: JL 13 = loxapine < clozapine. In two enzymatic systems (HRP/GSH and HRP/H2O2/ GSH) which generate the thiyl free radicals, clozapine produces a strong enhancement of the thiyl-radical EPR signal intensity while JL 13 and loxapine exhibit no or minimal effect on this signal. The redox potential values for the three derivatives confirm the spectro-photometric and EPR results. Following this study, we show that JL 13, although presenting a preclinical clozapine-like profile, appears less sensitive to oxidation than clozapine.
Liégeois
J F
JF
Laboratory of Medicinal Chemistry, University of Liège F1, Belgium.
Mouithys-Mickalad
A
A
Bruhwyler
J
J
Delarge
J
J
Petit
C
C
Kauffmann
J M
JM
Lamy
M
M
D014150:Antipsychotic Agents / Q000378:metabolism*; D002384:Catalysis; D003024:Clozapine / Q000031:analogs & derivatives* / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D008152:Loxapine / Q000378:metabolism; D010084:Oxidation-Reduction; D009195:Peroxidase / Q000378:metabolism; D019097:Spin Trapping; D013237:Stereoisomerism
D014150:Antipsychotic Agents; C108260:JL 13 compound; D009195:Peroxidase; D003024:Clozapine; D008152:Loxapine